product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Phospho-PLCγ2 (Tyr1217) Antibody
catalog :
3871P
quantity :
40 ul
price :
123 USD
clonality :
polyclonal
host :
rabbit
antigen modification :
phosphorylated
reactivity :
human, mouse, rat
application :
western blot
citations: 3
Published Application/Species/DilutionReference
  • western blot; human; fig 1a
  • western blot; mouse; fig 2b
Chen Z, Shojaee S, Buchner M, Geng H, Lee J, Klemm L, et al. Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia. Nature. 2015;521:357-61 pubmed publisher
Verkoczy L, Duong B, Skog P, Ait-Azzouzene D, Puri K, VELA J, et al. Basal B cell receptor-directed phosphatidylinositol 3-kinase signaling turns off RAGs and promotes B cell-positive selection. J Immunol. 2007;178:6332-41 pubmed
McPherson V, Sharma N, Everingham S, Smith J, Zhu H, Feng G, et al. SH2 domain-containing phosphatase-2 protein-tyrosine phosphatase promotes Fc epsilon RI-induced activation of Fyn and Erk pathways leading to TNF alpha release from bone marrow-derived mast cells. J Immunol. 2009;183:4940-7 pubmed publisher
product information
SKU :
3871P
Product-Name :
Phospho-PLCγ2 (Tyr1217) Antibody
Size :
40 ul
Price-(USD) :
123 USD
Species-x-Reactivity :
H, M, (R)
Applications :
Western blot
Product-Category :
Ca, cAMP and Lipid Signaling
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
150
Host :
Rabbit
Target :
PLCg2 (Tyr1217) phosphate
Primary-Protein :
PLCG2
Alt-Names :
1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2,PLC-IV,PLC-gamma-2,PLCG2,Phosphoinositide phospholipase C-gamma-2,Phospholipase C-IV,Phospholipase C-gamma-2,phospholipase C gamma 2,phospholipase C, gamma 2 (phosphatidylinositol-specific),phospholipase C, gamma 2 (phosphatidylyinositol-specific)
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.